Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach

NCT: NCT06547632 · TERMINATED

NCT IDNCT06547632
StatusTERMINATED
Start Date2025-07-31
Completion2026-02-27

Brief Summary

Ureteroscopy has been considered the best approach when treating renal stones smaller than 2 cm. This procedure is usually performed together with ureteral access sheaths, which helps protect the ureter mucosa and lowers intrarenal pressure. Recently, a new vacuum-assisted ureteral access sheath called ClearPetra has entered US market and allows for continuous stone fragmentation and aspiration. Because there is little information on comparing this device with traditional approach (no sheath or non-vacuum-assisted sheath) in American population, we aim to compare those devices in terms of their ability to clear the kidney from kidney stones, as well as reduce infection rates postoperatively.

Frequently Asked Questions

What is ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach?

ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach is a clinical trial registered under NCT06547632. Current status: TERMINATED.

What is the status of NCT06547632?

The current status of NCT06547632 (ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach) is: TERMINATED.

When did ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach start?

ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach started on 2025-07-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.